Hanson McClain Advisors »

Akero Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.7k 232 28.69
2024-06-30 $6.2k 232 26.76
2024-03-31 $5.9k 232 25.26
2023-12-31 $5.6k 241 23.35
2023-09-30 $37k 736 50.58
2023-06-30 $34k 736 46.69
2023-03-31 $28k 736 38.26
2022-12-31 $40k 736 54.80
2022-09-30 $25k 736 33.97
2022-06-30 $2.0k 200 10.00
2022-03-31 $3.0k 200 15.00